Dermatol. praxi. 2021;15(1):53-56 | DOI: 10.36290/der.2021.009

Isoprinosine: case reports

MUDr. Marie Tichá
Alergologie M & M, s. r. o., Přerov

Isoprinosine has a dual effect: immunomodulatory and virostatic. In dermatology, it can be used in treating a number of conditions, particularly including molluscum, verruca, herpes infections, and HPV infections. Dosage is individual depending on the severity and extent of the local finding as well as on the patient's comorbidities.

Keywords: Isoprinosine, verruca, molluscum, herpes labialis, HPV infection, immunity.

Published: April 6, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Tichá M. Isoprinosine: case reports. Dermatol. praxi. 2021;15(1):53-56. doi: 10.36290/der.2021.009.
Download citation

References

  1. Bystroň J. Imunomodulační léčba v pediatrii. Pediatr. praxi 2010; 11(5): 298-304.
  2. Cohen A, et al. Clinical study of various aetiology treated with methisoprinol syrup. La Prensa Medica Argentina 1973; 60(8): 267-278.
  3. Lo Iacono F, et al. Methisoprinol in the treatment of certain dieases of the upper respiratory tract in children. Aggiornamento pediatrico 1982; 33(1-2): 85-90.
  4. Robert J, et al. Prévention des infections respiratoires récidivantes de l'enfant par Isoprinosine®. Gazette Médicale 1987; 94(45): 60-62.
  5. Bystroň J. Možnosti imunomodulační léčby při řešení recidivujících infekcí dýchacích cest.Med. praxi 2013; 10(1): 16-21.
  6. Hrubiško M. Imunoterapia v ambulantnej praxi - čo možeme očakávať od chemických imunomodulátorov? Ambulantná terapia 2009; 7(1): 6-9.
  7. Souhrn údajů o přípravku Isoprinosine, 28. 12. 2018. SÚKL, 42/198/81-C.
  8. Ahmed RS, et al. Inosine Acedoben Dimepranol promotes an early and sustained increase in the natural killer cell component of circulating lymphocytes: A clinical trial supporting anti‑viral indications. Int Immunopharmacol. 2017; 42: 108-114. Go to original source... Go to PubMed...
  9. Petrů V. Imunoterapie dětí s recidivujícími respiračními infekcemi. Pediatr. praxi 2012; 13(5): 304-310.




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.